Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 1 (January)

1. Pancreatic cancer presenting as a Sister Mary Joseph's nodule: case report and update of the literature.
   Pancreas, 34(1): 161-4. [Abstract] [Full-text]
2. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.
   J Thorac Cardiovasc Surg, 133(1): 104-10. [Abstract] [Full-text]
3. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
   Cancer, 109(1): 100-8. [Abstract] [Full-text]
4. Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis.
   Mol Carcinog, 46(1): 49-59. [Abstract] [Full-text]
5. The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry.
   Genes Chromosomes Cancer, 46(3): 277-87. [Abstract] [Full-text]
6. SunSafe in the Middle School Years: a community-wide intervention to change early-adolescent sun protection.
   Pediatrics, 119(1): e247-56. [Abstract] [Full-text]
7. Imaging of metastatic melanoma.
   Cancer Imaging, 6: 204-8. [Abstract] [Full-text]
8. Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin.
   Cancer Res, 67(1): 276-80. [Abstract] [Full-text]
9. A 30-year history of CD4+ vesiculo-bullous mycosis fungoides and multiple visceral malignancies.
   Australas J Dermatol, 48(1): 46-9. [Abstract] [Full-text]
10. Retrospective review of primary melanomas excised at Waikato Hospital, New Zealand, 2002-2003.
    Australas J Dermatol, 48(1): 14-7. [Abstract] [Full-text]
11. Therapeutic options for Bowen's disease.
    Australas J Dermatol, 48(1): 1-8; quiz 9-10. [Abstract] [Full-text]
12. Lymphomatoid keratosis: an epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases.
    Arch Dermatol, 143(1): 53-9. [Abstract] [Full-text]
13. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Arch Dermatol, 143(1): 45-50. [Abstract] [Full-text]
14. Efficacy of a partner assistance intervention designed to increase skin self-examination performance.
    Arch Dermatol, 143(1): 37-41. [Abstract] [Full-text]
15. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study.
    Arch Dermatol, 143(1): 30-6. [Abstract] [Full-text]
16. Visual screening for malignant melanoma: a cost-effectiveness analysis.
    Arch Dermatol, 143(1): 21-8. [Abstract] [Full-text]
17. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
    J Invest Dermatol, 127(2): 276-80. [Abstract] [Full-text]
18. Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.
    J Invest Dermatol, 127(2): 439-46. [Abstract] [Full-text]
19. Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression.
    J Invest Dermatol, 127(2): 387-93. [Abstract] [Full-text]
20. Medial canthal reconstruction with glabellar combined Rintala flaps.
    Plast Reconstr Surg, 119(2): 537-41. [Abstract] [Full-text]
21. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
    Genes Dev, 21(2): 206-20. [Abstract] [Full-text]
22. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
    Hum Pathol, 38(2): 351-8. [Abstract] [Full-text]
23. Keyhole limpet hemocyanin potentiates standard immunotherapy for melanoma.
    Am J Surg, 193(2): 284-7. [Abstract] [Full-text]
24. Influence of provider and practice characteristics on melanoma care.
    Am J Surg, 193(2): 206-12. [Abstract] [Full-text]
25. Chronic arsenic poisoning: a global health issue -- a report of multiple primary cancers.
    J Cutan Pathol, 34(2): 203-6. [Abstract] [Full-text]
26. Cutaneous granular cell tumor with epidermal involvement: a potential mimic of melanocytic neoplasia.
    J Cutan Pathol, 34(2): 188-94. [Abstract] [Full-text]
27. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions.
    J Cutan Pathol, 34(2): 174-80. [Abstract] [Full-text]
28. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    J Cutan Pathol, 34(2): 166-73. [Abstract] [Full-text]
29. Significance of cell kinetic parameters in the prognosis of malignant melanoma: a review.
    J Cutan Pathol, 34(2): 139-45. [Abstract] [Full-text]
30. Fine-needle aspiration cytologic diagnosis of metastatic melanotic schwannoma: familial case of a mother and daughter with Carney's complex and literature review.
    Diagn Cytopathol, 35(2): 130-4. [Abstract] [Full-text]
31. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review.
    Int J Cancer, 120(5): 1116-22. [Abstract] [Full-text]
32. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Am J Surg Pathol, 31(2): 304-10. [Abstract] [Full-text]
33. Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit.
    J Clin Pathol, 60(2): 129-44. [Abstract] [Full-text]
34. Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.
    J Clin Pathol, 60(2): 145-59. [Abstract] [Full-text]
35. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
    J Clin Pathol, 60(2): 190-4. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.